News & Updates

Lying flat prior to thrombectomy good for LVO stroke

14 Feb 2024 by

Positioning patients with large vessel occlusion (LVO) stroke flat on the bed prior to thrombectomy helps improve neurologic outcomes in the randomized controlled ZODIAC* trial.

Lying flat prior to thrombectomy good for LVO stroke

14 Feb 2024

Serious infections prevalent in RTX-treated patients with SLE

13 Feb 2024

A recent study has reported the prevalence of serious infection (SI) among patients with systemic lupus erythematosus (SLE) following treatment with rituximab (RTX).

Serious infections prevalent in RTX-treated patients with SLE

13 Feb 2024

Immunotherapy, TACE-based regimen may reshape HCC treatment landscape

13 Feb 2024 by

In the EMERALD-1 trial, durvalumab plus bevacizumab (D+B) combined with transarterial chemoembolization (TACE) improved progression-free survival (PFS) in individuals with unresectable hepatocellular carcinoma (HCC) eligible for embolization.

Immunotherapy, TACE-based regimen may reshape HCC treatment landscape

13 Feb 2024

IV ginkgo may boost brain recovery after stroke

13 Feb 2024 by

In a placebo-controlled trial, active components of Ginkgo biloba given intravenously for 14 days helps improve cognitive recovery among patients following an acute ischaemic stroke.

IV ginkgo may boost brain recovery after stroke

13 Feb 2024

Prophylactic oropharyngeal surfactant does little to reduce intubation risk in preemies

12 Feb 2024

Administration of surfactant into the oropharynx of neonates delivered before 29 weeks of gestation falls short of reducing the rate of intubation in the first 120 hours of life, according to the results of POPART*.

Prophylactic oropharyngeal surfactant does little to reduce intubation risk in preemies

12 Feb 2024

Sibeprenlimab shows promise in IgA nephropathy

11 Feb 2024

In the treatment of patients with IgA nephropathy, the use of sibeprenlimab, a humanized IgG2 monoclonal antibody that binds to and neutralizes a proliferation-inducing ligand (APRIL), appears to lead to a significant reduction in proteinuria, according to a phase II trial.

Sibeprenlimab shows promise in IgA nephropathy

11 Feb 2024

Glucagon/GLP-1 receptor dual agonist for weight loss shows therapeutic potential

11 Feb 2024

The glucagon/GLP-1 receptor dual agonist survodutide appears to be safe and induce weight loss in individuals with obesity, according to data from a phase II dose-finding trial.

Glucagon/GLP-1 receptor dual agonist for weight loss shows therapeutic potential

11 Feb 2024

Novel anti-influenza A virus inhibitor works in patients with uncomplicated flu infection

10 Feb 2024

Treatment with the anti-influenza A virus inhibitor onradivir is safe and leads to symptom improvement and viral load reduction in adults with uncomplicated influenza infection, according to data from a phase II trial.

Novel anti-influenza A virus inhibitor works in patients with uncomplicated flu infection

10 Feb 2024

Erdafitinib on par with pembrolizumab in metastatic urothelial cancer

07 Feb 2024

Treatment with erdafitinib or pembrolizumab results in similar median overall survival (OS) in pretreated patients with advanced or metastatic urothelial cancer (mUC) with select fibroblast growth factor receptor (FGFR) alterations (FGFRalt), a study has shown. Safety results are also comparable to the known profiles for both regimens in this patient population.

Erdafitinib on par with pembrolizumab in metastatic urothelial cancer

07 Feb 2024

Elevated INR predicts mortality in DOAC-treated patients

06 Feb 2024

Among hospitalized patients treated with direct oral anticoagulants (DOACs), an elevated international normalized ratio (INR) upon admission may spell an increased risk for in-hospital death or mortality during the first year following hospitalization, suggests a study.

Elevated INR predicts mortality in DOAC-treated patients

06 Feb 2024

News & Updates

Filter by Specialty:

Specialty:

Lying flat prior to thrombectomy good for LVO stroke

Lying flat prior to thrombectomy good for LVO stroke

Serious infections prevalent in RTX-treated patients with SLE

Serious infections prevalent in RTX-treated patients with SLE

Immunotherapy, TACE-based regimen may reshape HCC treatment landscape

Immunotherapy, TACE-based regimen may reshape HCC treatment landscape

IV ginkgo may boost brain recovery after stroke

IV ginkgo may boost brain recovery after stroke

Prophylactic oropharyngeal surfactant does little to reduce intubation risk in preemies

Prophylactic oropharyngeal surfactant does little to reduce intubation risk in preemies

Sibeprenlimab shows promise in IgA nephropathy

Sibeprenlimab shows promise in IgA nephropathy

Glucagon/GLP-1 receptor dual agonist for weight loss shows therapeutic potential

Glucagon/GLP-1 receptor dual agonist for weight loss shows therapeutic potential

Novel anti-influenza A virus inhibitor works in patients with uncomplicated flu infection

Novel anti-influenza A virus inhibitor works in patients with uncomplicated flu infection

Erdafitinib on par with pembrolizumab in metastatic urothelial cancer

Erdafitinib on par with pembrolizumab in metastatic urothelial cancer

Elevated INR predicts mortality in DOAC-treated patients

Elevated INR predicts mortality in DOAC-treated patients